A carregar...
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
BACKGROUND: Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. METHODS: This was an open-label, multicentre, randomized c...
Na minha lista:
| Publicado no: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454592/ https://ncbi.nlm.nih.gov/pubmed/32812039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa334 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|